RCKT R&D Expense Growth
Rocket Pharmaceuticals Inc · R&D Expense Growth
RCKT R&D Expense Growth
Latest reported-17.07%period ending
RCKT FY R&D Growth (YoY) (0.00% → -17.07%)
Latest values, visible window
High-resolution chart · PNG
RCKT r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -17.0686% | |
| -8.1023% | |
| 12.5458% | |
| 31.9535% | |
| 17.9485% | |
| 81.468% | |
| 10.0488% | |
| 275.3259% | |
| -55.6261% | |
| 154.7794% | |
| 124.4993% | |
| 4.9156% | |
| 50.48% | |
| 0% |